Day: March 28, 2026

IPO

Guangdong Huayan Robotics Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process, and Key Dates (March 2026) 236

Minichart

March 28, 2026

Guangdong Huayan Robotics Co., Ltd. IPO Analysis – March 20,...

Continue Reading 0

us corporate news

Enveric Biosciences: Advancing Non-Hallucinogenic Psychedelic Drug Development for Mental Health Disorders

Minichart

March 28, 2026

Enveric Biosciences, Inc. 2025 Annual Report: Key Insights f...

Continue Reading 0

IPO

Epiworld International Co., Ltd. (Stock Code: 2726) Announces HKEX Global Offering Details and IPO Application Timeline for 2026

Minichart

March 28, 2026

Epiworld International Co., Ltd. IPO Analysis – March 20, 20...

Continue Reading 0

us corporate news

K&F Growth Capital II 2026 Annual Report: Business Strategy, Risk Factors, and SPAC Investment Insights

Minichart

March 28, 2026

KF Growth Acquisition Corp. II Annual Report: Key Investor T...

Continue Reading 0

us corporate news

Gesher Acquisition Corp. II 2025 Annual Report: Business Strategy, SPAC Criteria, and Risk Factors Explained

Minichart

March 28, 2026

Gesher I Acquisition Corp. 2025 Annual Report: Key Investor ...

Continue Reading 0

IPO

Financial Analysis Report

Minichart

March 28, 2026

Beijing Tong Ren Tang Healthcare Investment Co., Ltd. IPO An...

Continue Reading 0

us corporate news

Immix Biopharma, Inc. 2025 Annual Report Amendment: Financial Statements, Auditor Correction, and Company Overview

Minichart

March 28, 2026

Immix Biopharma, Inc. Files Amendment No. 1 to Annual Report...

Continue Reading 0

IPO

Hangzhou Diagens Biotechnology Co., Ltd. Hong Kong IPO: Key Dates, Offer Details & Application Guide 2026 2467

Minichart

March 28, 2026

Hangzhou Diagens Biotechnology Co., Ltd. IPO: Key Details, A...

Continue Reading 0

us corporate news

Asset Acquisition Corp. SPAC Targets Space, Technology, and Defense Sectors for Business Combination Opportunities

Minichart

March 28, 2026

Space Asset Acquisition Corp. 10-K Analysis: Key Takeaways f...

Continue Reading 0

us corporate news

AIM ImmunoTech 2025 Annual Report: Focus on Ampligen for Pancreatic Cancer, Clinical Trials, and R&D Highlights

Minichart

March 28, 2026

AIM ImmunoTech Inc. 2025 Annual Report: Key Highlights for I...

Continue Reading 0